Health TrialsbyHealthPanel

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

ConditionsTakayasu Arteritis With Pulmonary Artery InvolvementPercutaneous Transluminal Pulmonary AngioplastyPAH Targeted Medication
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChinese Pulmonary Vascular Disease Research Group

About this trial

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients diagnosed with Takayasu arteries with pulmonary arteries involvement

Disqualifiers

Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis

Trial population

patients diagnosed with Takayasu arteries with pulmonary arteries involvement received either medical or percutaneous transluminal pulmonary angioplasty

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Percutaneous transluminal pulmonary angioplasty

    Device

    Percutaneous transluminal pulmonary angioplasty

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

all cause death

all cause death

Time frame
2014/1/1-2042/12/31
2

mean pulmonary arterial pressure change

change of mean pulmonary arterial pressure after treatment

Time frame
2014/1/1-2042/12/31
3

pulmonary vascular resistance change

chagne of pulmonary vascular resistance after treatment

Time frame
2014/1/1-2042/12/31
4

6MWD change

change of six minute walk distance after treatment

Time frame
2014/1/1-2042/12/31

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chinese Pulmonary Vascular Disease Research Group

Lead sponsor

Source ClinicalTrials.gov
Apply now